ArticleAntibiotics (Basel, Switzerland)2025
Synthesis and Structure-Activity Relationship Study of 2-(amino)quinazolin-4(3
Jun Young Lee, Hyunjung Lee, Sungmin Kim, Jihwan Gim, Yunmi Lee, Chae Jo Lim, Hyun-Seob Song, Hyeung-Geun Park, Soojin Jang, Chul Min Park
Abstract read
In one paragraphArticle in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Jun Young LeeInfectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.ORCID 0000-0001-7751-2133 Hyunjung LeeAntibacterial Resistance Laboratory, Institut Pasteur Korea, Seongam-si 13488, Republic of Korea.
Sungmin KimInfectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.
Jihwan GimInfectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.
Yunmi LeeAntibacterial Resistance Laboratory, Institut Pasteur Korea, Seongam-si 13488, Republic of Korea.
Chae Jo LimData Convergence Drug Research Center, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.ORCID 0000-0002-4311-1857 Hyun-Seob SongDepartment of Biological Systems Engineering, University of Nebraska-Lincoln, Lincoln, NE 68588, USA.ORCID 0000-0002-2154-6358 Hyeung-Geun ParkResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
Soojin JangAntibacterial Resistance Laboratory, Institut Pasteur Korea, Seongam-si 13488, Republic of Korea.
Chul Min ParkInfectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
2-(Amino)quinazolin-4(3H)-oneantibacterialmethicillin-resistant Staphylococcus aureus (MRSA)multi-antibiotic-resistancequinazoline
Identifiers
PMID41148660
PMCPMC12561453
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390